Drug targeting in <i>Leishmania donovani</i> infections using tuftsin‐bearing liposomes as drug vehicles

P. Y. Guru, Ajay Agrawal, U.K. Singha, Arun Singhal, Chhitar M. Gupta

FEBS Letters · 1989 · 73 citations · 7 references

Concepts

Abstract

The efficacy of sodium stibogluconate against Leishmania donovani infections was markedly enhanced by encapsulating this drug in tuftsin-bearing liposomes. Also, pretreatment of the animals with these liposomes (free of drug) rendered them resistant to this infection, possibly by activating the host's macrophages. These results demonstrate that tuftsin-bearing liposomes besides delivering the drug to the target cells could also enhance the nonspecific resistance against infections, thus offering an additional advantage over the use of tuftsin-free liposomes as drug carriers in leishmania therapy.

References

7